SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2013 Research Report

[February 05, 2014]

Research and Markets: Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2013 Research Report

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/p9m7xt/chemotherapy) has announced the addition of the "Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2013" report to their offering.

'Chemotherapy Induced Myelosuppression - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Chemotherapy Induced Myelosuppression, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chemotherapy Induced Myelosuppression.

Scope

- A snapshot of the global therapeutic scenario for Chemotherapy Induced Myelosuppression.

- A review of the Chemotherapy Induced Myelosuppression products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discover till registration stages.


- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Chemotherapy Induced Myelosuppression pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

Introduction

Chemotherapy Induced Myelosuppression Overview

Therapeutics Development

Pipeline Products for Chemotherapy Induced Myelosuppression - Overview

Pipeline Products for Chemotherapy Induced Myelosuppression - Comparative Analysis

Chemotherapy Induced Myelosuppression - Therapeutics under Development by Companies

Chemotherapy Induced Myelosuppression - Therapeutics under Investigation by Universities/Institutes

Chemotherapy Induced Myelosuppression - Pipeline Products Glance

Clinical Stage Products

Early Stage Products

Chemotherapy Induced Myelosuppression - Products under Development by Companies

Chemotherapy Induced Myelosuppression - Products under Investigation by Universities/Institutes

Chemotherapy Induced Myelosuppression - Companies Involved in Therapeutics Development

Biothera, Inc.

G1 Therapeutics, Inc.

Berg Pharma, LLC

Chemotherapy Induced Myelosuppression - Therapeutics Assessment

Drug Profiles

PGG beta-glucan - Drug Profile

calcitriol - Drug Profile

dinoprostone - Drug Profile

GZ-381 - Drug Profile

SHIP1 Inhibitors - Drug Profile

Chemotherapy Induced Myelosuppression - Recent Pipeline Updates

Chemotherapy Induced Myelosuppression - Dormant Projects

Companies Mentioned

Biothera, Inc.

G1 Therapeutics, Inc.

Berg Pharma, LLC

For more information visit http://www.researchandmarkets.com/research/p9m7xt/chemotherapy

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy